The heart-1 Trial of VERVE-101
February 21, 2024 | Andrew Bellinger, Sek Kathiresan, and C. Michael Gibson talk about the phase 1b trial of what investigators hope may be a one-time genetic fix for hyperlipidemia. |
TCTMD Talking Points
2024-02-21T14:00:00Z